Cost-effectiveness of nonavalent HPV vaccine in Norway considering current empirical data and validation.

Prev Med

Harvard T.H. Chan School of Public Health, Center for Health Decision Science, Boston, MA, USA; Department of Health Management and Health Economics, University of Oslo, Oslo, Norway.

Published: September 2021

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ypmed.2021.106688DOI Listing

Publication Analysis

Top Keywords

cost-effectiveness nonavalent
4
nonavalent hpv
4
hpv vaccine
4
vaccine norway
4
norway considering
4
considering current
4
current empirical
4
empirical data
4
data validation
4
cost-effectiveness
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!